title: Angiogenesis and cell proliferation in human craniopharyngioma xenografts in nude mice.
abstract: OBJECTIVE
  Craniopharyngioma is one of the most common congenital tumors of the sellar and suprasellar regions and accounts for between 4 and 6% of all intracranial tumors. Its oncogenesis and biological behavior have not been well studied, and neither a cell line nor an animal model have been established. To better understand the tumor and improve its clinical management, the authors investigated the angiogenesis and cellular proliferation in subcutaneous craniopharyngioma xenografts obtained by implanting human tumor cells into athymic nude mice.
  
  
  METHODS
  Human craniopharyngioma cells obtained from surgical specimens were subcutaneously implanted into BALB/c-nu/nu nude mice to establish a preliminary animal model of a transplanted tumor. Immunohistochemical staining with streptavidin-peroxidase complex was used to identify the cell phenotype and to evaluate the angiogenesis and proliferation in the xenografts. Expression of cytokeratin, minichromosome maintenance deficient 6 (MCM6) protein, and endothelial cell marker CD34 on the xenograft sections were assayed quantitatively by computer-assisted microscopy. Twenty-seven surviving subcutaneous xenografts were obtained in 15 nude mice. The total implantation success rate was 28.12% (adamantine epithelioma [AE], 37.50%; squamous papillary tumor [SPT], 18.75%). Formation of capillaries and cell proliferation were observed in all of these xenografts. Microvessel density and degree of MCM6 immunostaining were positively correlated in the surviving grafts (r = 0.410, p < 0.05), but there was no significant difference in these variables between the AE and SPT groups (p > 0.05).
  
  
  CONCLUSIONS
  A preliminary animal model of human craniopharyngioma was established in the nude mouse by heterotopic implantation. Surviving xenografts maintained their vascularization and proliferation activities until harvesting at 12 weeks.
authors.affiliation: Department of Neurosurgery, West China Hospital, Sichuan University, People's Republic of China. Jianguo_1229@sina.com
authors.forename: Jianguo
authors.initials: J
authors.lastname: Xu
authors.forename: Chao
authors.initials: C
authors.lastname: You
authors.forename: Sizhong
authors.initials: S
authors.lastname: Zhang
authors.forename: Siqing
authors.initials: S
authors.lastname: Huang
authors.forename: Bowen
authors.initials: B
authors.lastname: Cai
authors.forename: Zhenggui
authors.initials: Z
authors.lastname: Wu
authors.forename: Hao
authors.initials: H
authors.lastname: Li
mesh_terms: D000818:Animals; D001808:Blood Vessels / Q000473:pathology; D018797:Cell Cycle Proteins / Q000378:metabolism; D049109:Cell Proliferation; D003397:Craniopharyngioma / Q000098:blood supply* / Q000378:metabolism / Q000473:pathology*; D005260:Female; D006085:Graft Survival; D006801:Humans; D008297:Male; D051379:Mice; D008819:Mice, Nude; D064151:Minichromosome Maintenance Complex Component 6; D009364:Neoplasm Recurrence, Local; D009368:Neoplasm Transplantation; D009389:Neovascularization, Pathologic / Q000473:pathology*; D010911:Pituitary Neoplasms / Q000098:blood supply* / Q000378:metabolism / Q000473:pathology*; D014183:Transplantation, Heterologous
chemical_list: D018797:Cell Cycle Proteins; C103258:MCM6 protein, human; D064151:Minichromosome Maintenance Complex Component 6